Tonix Pharmaceuticals Holding Corp (TNXP)
0.2699
-0.05
(-15.66%)
USD |
NASDAQ |
Mar 28, 09:40
Tonix Pharmaceuticals Cash from Investing (TTM): -33.31M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -33.31M |
June 30, 2023 | -41.31M |
March 31, 2023 | -31.73M |
December 31, 2022 | -48.15M |
September 30, 2022 | -69.10M |
June 30, 2022 | -68.03M |
March 31, 2022 | -55.02M |
December 31, 2021 | -35.31M |
September 30, 2021 | -14.22M |
June 30, 2021 | -10.48M |
March 31, 2021 | -9.069M |
December 31, 2020 | -8.564M |
September 30, 2020 | -4.035M |
June 30, 2020 | -0.021M |
March 31, 2020 | -0.01M |
December 31, 2019 | -0.017M |
September 30, 2019 | -0.011M |
June 30, 2019 | -0.012M |
March 31, 2019 | -0.011M |
December 31, 2018 | -0.006M |
September 30, 2018 | -0.01M |
June 30, 2018 | -0.007M |
March 31, 2018 | 2.473M |
December 31, 2017 | 7.169M |
September 30, 2017 | 11.03M |
Date | Value |
---|---|
June 30, 2017 | 16.27M |
March 31, 2017 | 16.52M |
December 31, 2016 | 16.55M |
September 30, 2016 | 10.77M |
June 30, 2016 | -16.57M |
March 31, 2016 | -19.45M |
December 31, 2015 | -24.17M |
September 30, 2015 | -22.37M |
June 30, 2015 | -0.438M |
March 31, 2015 | -0.39M |
December 31, 2014 | -0.392M |
September 30, 2014 | -0.274M |
June 30, 2014 | -0.122M |
March 31, 2014 | -0.017M |
December 31, 2013 | -0.015M |
September 30, 2013 | -0.0083M |
June 30, 2013 | -0.0021M |
March 31, 2013 | -0.036M |
December 31, 2012 | -0.036M |
September 30, 2012 | -0.0358M |
June 30, 2012 | -0.0339M |
March 31, 2012 | -0.0147M |
December 31, 2011 | 0.0003M |
September 30, 2011 | -0.094M |
June 30, 2011 | -0.094M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-69.10M
Minimum
Sep 2022
-0.01M
Maximum
Mar 2020
-22.55M
Average
-10.48M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
ACADIA Pharmaceuticals Inc | 32.00M |
PetVivo Holdings Inc | -0.4099M |
Acurx Pharmaceuticals Inc | -- |
Eli Lilly and Co | -7.153B |
Kezar Life Sciences Inc | 76.05M |